Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Positive allosteric modulation of alpha 7 nicotinic acetylcholine receptors enhances recognition memory and cognitive flexibility in rats
Agnieszka Nikiforuk, Tomasz Kos, Agnieszka Potasiewicz, et al.
European Neuropsychopharmacology (2015) Vol. 25, Iss. 8, pp. 1300-1313
Closed Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Role of Plant Derived Alkaloids and Their Mechanism in Neurodegenerative Disorders
Ghulam Hussain, Azhar Rasul, Haseeb Anwar, et al.
International Journal of Biological Sciences (2018) Vol. 14, Iss. 3, pp. 341-357
Open Access | Times Cited: 277
Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson’s disease
Santiago Perez‐Lloret, Francisco J. Barrantes
npj Parkinson s Disease (2016) Vol. 2, Iss. 1
Open Access | Times Cited: 183
Understanding the Bases of Function and Modulation of α7 Nicotinic Receptors: Implications for Drug Discovery
Jeremías Corradi, Cecilia Bouzat
Molecular Pharmacology (2016) Vol. 90, Iss. 3, pp. 288-299
Open Access | Times Cited: 151
Cholinergic circuits in cognitive flexibility
Vânia F. Prado, Helena Janíčková, Mohammed Al‐Onaizi, et al.
Neuroscience (2016) Vol. 345, pp. 130-141
Closed Access | Times Cited: 125
The current agonists and positive allosteric modulators of α 7 nAChR for CNS indications in clinical trials
Taoyi Yang, Ting Xiao, Qi Sun, et al.
Acta Pharmaceutica Sinica B (2017) Vol. 7, Iss. 6, pp. 611-622
Open Access | Times Cited: 103
α7 nicotinic acetylcholine receptors as therapeutic targets in schizophrenia: Update on animal and clinical studies and strategies for the future
Alvin V. Terry, Patrick M. Callahan
Neuropharmacology (2020) Vol. 170, pp. 108053-108053
Open Access | Times Cited: 71
Orthosteric and allosteric potentiation of heteromeric neuronal nicotinic acetylcholine receptors
Jingyi Wang, Jon Lindstrom
British Journal of Pharmacology (2017) Vol. 175, Iss. 11, pp. 1805-1821
Open Access | Times Cited: 80
Adolescent binge ethanol exposure alters specific forebrain cholinergic cell populations and leads to selective functional deficits in the prefrontal cortex
Gina M. Fernandez, Lisa M. Savage
Neuroscience (2017) Vol. 361, pp. 129-143
Open Access | Times Cited: 66
Neuromodulators and Long-Term Synaptic Plasticity in Learning and Memory: A Steered-Glutamatergic Perspective
Amjad H. Bazzari, H. Rheinallt Parri
Brain Sciences (2019) Vol. 9, Iss. 11, pp. 300-300
Open Access | Times Cited: 62
First in human trial of a type I positive allosteric modulator of alpha7-nicotinic acetylcholine receptors: Pharmacokinetics, safety, and evidence for neurocognitive effect of AVL-3288
Kelvin W. Gee, Ann Olincy, Richard E. Kanner, et al.
Journal of Psychopharmacology (2017) Vol. 31, Iss. 4, pp. 434-441
Open Access | Times Cited: 53
Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors reverse ketamine-induced schizophrenia-like deficits in rats
Agnieszka Nikiforuk, Tomasz Kos, Małgorzata Hołuj, et al.
Neuropharmacology (2015) Vol. 101, pp. 389-400
Closed Access | Times Cited: 51
Scalable, One-Pot, Microwave-Accelerated Tandem Synthesis of Unsymmetrical Urea Derivatives
Abhijit Kulkarni, Sumanta Garai, Ganesh A. Thakur
The Journal of Organic Chemistry (2016) Vol. 82, Iss. 2, pp. 992-999
Closed Access | Times Cited: 49
The combination of memantine and galantamine improves cognition in rats: The synergistic role of the α7 nicotinic acetylcholine and NMDA receptors
Agnieszka Nikiforuk, Agnieszka Potasiewicz, Tomasz Kos, et al.
Behavioural Brain Research (2016) Vol. 313, pp. 214-218
Closed Access | Times Cited: 47
The role of nicotinic cholinergic neurotransmission in delusional thinking
Michael Caton, Enrique L. M. Ochoa, Francisco J. Barrantes
Schizophrenia (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 40
3-Furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic receptor, reverses schizophrenia-like cognitive and social deficits in rats
Agnieszka Potasiewicz, Małgorzata Hołuj, Tomasz Kos, et al.
Neuropharmacology (2016) Vol. 113, pp. 188-197
Closed Access | Times Cited: 45
Targeting the cholinergic system in Parkinson’s disease
Changliang Liu
Acta Pharmacologica Sinica (2020) Vol. 41, Iss. 4, pp. 453-463
Open Access | Times Cited: 37
Water‐soluble variant of human Lynx1 positively modulates synaptic plasticity and ameliorates cognitive impairment associated with α7‐nAChR dysfunction
Захар О. Шенкарев, Mikhail A. Shulepko, М. Л. Бычков, et al.
Journal of Neurochemistry (2020) Vol. 155, Iss. 1, pp. 45-61
Open Access | Times Cited: 32
Role of Alpha-7-Nicotinic Acetylcholine Receptor in Alzheimer's Disease
Sushma Singh, Neetu Agrawal, Ahsas Goyal
CNS & Neurological Disorders - Drug Targets (2023) Vol. 23, Iss. 3, pp. 384-394
Closed Access | Times Cited: 11
Nicotinic ligands as multifunctional agents for the treatment of neuropsychiatric disorders
Alvin V. Terry, Patrick M. Callahan, Caterina M. Hernandez
Biochemical Pharmacology (2015) Vol. 97, Iss. 4, pp. 388-398
Open Access | Times Cited: 39
The effects of a 5-HT5A receptor antagonist in a ketamine-based rat model of cognitive dysfunction and the negative symptoms of schizophrenia
Agnieszka Nikiforuk, Małgorzata Hołuj, Tomasz Kos, et al.
Neuropharmacology (2016) Vol. 105, pp. 351-360
Closed Access | Times Cited: 36
Therapeutic potential of α7 nicotinic receptor agonists to regulate neuroinflammation in neurodegenerative diseases
Laura Foucault‐Fruchard, Daniel Antier
Neural Regeneration Research (2017) Vol. 12, Iss. 9, pp. 1418-1418
Open Access | Times Cited: 35
Nicotinic Acetylcholine Receptor Ligands, Cognitive Function, and Preclinical Approaches to Drug Discovery
Alvin V. Terry, Patrick M. Callahan
Nicotine & Tobacco Research (2018) Vol. 21, Iss. 3, pp. 383-394
Open Access | Times Cited: 35
Effects of haloperidol, olanzapine, ziprasidone, and PHA‐543613 on spatial learning and memory in the Morris water maze test in naïve and MK‐801‐treated mice
Houxu Ning, Dong Cao, Haidong Wang, et al.
Brain and Behavior (2017) Vol. 7, Iss. 8
Open Access | Times Cited: 31
Pro‐cognitive activity in rats of 3‐furan‐2‐yl‐N‐p‐tolyl‐acrylamide, a positive allosteric modulator of the α7 nicotinic acetylcholine receptor
Agnieszka Potasiewicz, Tomasz Kos, Federica Ravazzini, et al.
British Journal of Pharmacology (2015) Vol. 172, Iss. 21, pp. 5123-5135
Open Access | Times Cited: 29
Brain and Cognition for Addiction Medicine: From Prevention to Recovery Neural Substrates for Treatment of Psychostimulant-Induced Cognitive Deficits
Manoranjan S. D’Souza
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top